Page last updated: 2024-10-31

mexiletine and Paralysis, Hyperkalemic Periodic

mexiletine has been researched along with Paralysis, Hyperkalemic Periodic in 2 studies

Mexiletine: Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.
mexiletine : An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol.

Paralysis, Hyperkalemic Periodic: An autosomal dominant familial disorder which presents in infancy or childhood and is characterized by episodes of weakness associated with hyperkalemia. During attacks, muscles of the lower extremities are initially affected, followed by the lower trunk and arms. Episodes last from 15-60 minutes and typically occur after a period of rest following exercise. A defect in skeletal muscle sodium channels has been identified as the cause of this condition. Normokalemic periodic paralysis is a closely related disorder marked by a lack of alterations in potassium levels during attacks of weakness. (Adams et al., Principles of Neurology, 6th ed, p1481)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fontaine, B1
Weckbecker, K1
Würz, A1
Mohammadi, B1
Mansuroglu, T1
George, AL1
Lerche, H1
Dengler, R1
Lehmann-Horn, F1
Mitrovic, N1

Reviews

1 review available for mexiletine and Paralysis, Hyperkalemic Periodic

ArticleYear
[Ion-channel related muscular diseases].
    La Revue de medecine interne, 1999, Volume: 20, Issue:9

    Topics: Acetazolamide; Anti-Arrhythmia Agents; Anticonvulsants; Carbamazepine; Humans; Hypokalemic Periodic

1999

Other Studies

1 other study available for mexiletine and Paralysis, Hyperkalemic Periodic

ArticleYear
Different effects of mexiletine on two mutant sodium channels causing paramyotonia congenita and hyperkalemic periodic paralysis.
    Neuromuscular disorders : NMD, 2000, Volume: 10, Issue:1

    Topics: Cell Line; Homeostasis; Humans; Mexiletine; Models, Molecular; Mutation; Myotonic Disorders; Paralys

2000